U.S. States Attempting to Clamp Down On Big Pharma’s Rising Drug Costs
The global pharmaceutical market will reach $1.12 trillion by 2022. And according to The New York Times, states across the country are clamping down on pharmaceutical companies, forcing them to disclose pricing information and justify price increases. In fact, 24 states have passed a total of 27 bills throughout 2018 to block rising prescription drug […]
Continue Reading